返回 A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® EP Participates in a Free Clinic in Jiangxi

[2017-07-11] 

Pingxiang, China – On the occasion of celebrating the 96th anniversary of Communist Party of China, a free clinic activity was held in Pingxiang of Jiangxi Province. Professor Dening Liao and Professor Yusheng Ren of Shanghai Changzheng Hospital and other experts from Shanghai top hospitals attended the event.
 
During this free clinic activity, Professor Dening Liao, with the assistance from Professor Genqing Zhou of Shanghai General Hospital, used Columbus™ 3D EP Navigation System ("Columbus™"),in-house developed by Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP"), to do cardiac electrophysiological examination and radiofrequency ablation for eight arrhythmia patients. Such kind of operation demonstration allowed physicians in attendance to learn high-end operative techniques. According to the attendees, the procedure demonstrations largely enhanced the understanding of local medical staff in treating arrhythmias and indicated the development trend for similar procedures. Currently, an increasingly more physicians are using 3D mapping systems in radiofrequency ablation. Columbus™ is the first domestically developed 3D EP navigation system that features real time electromagnetic device tracking with cardiac motion compensation. It offers vivid 3D simulation of the catheter deflectable segment and accurate geometric reconstruction of intra cardiac chambers. Compared with the traditional procedure under X-ray fluoroscopy, Columbus™ provides a comprehensive image solution that combines cardiac electrical mapping with anatomy structure for physicians to better treat patients with complex arrhythmias. Furthermore, the use of Columbus™ greatly reduces the exposure to X-ray for patients and physicians during the procedures.
 
In this free clinic activity, physicians provided high-quality medical service for local residents, which strongly enhanced the communications between medical staff of Shanghai and Jiangxi and promoted the development of Jiangxi healthcare industry. In the end, Professor Dening Liao encouraged more medical professionals to give back to their local communities with their expertise.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2017 MicroPort Scientific Corporation

CONTACT:
Amanda Zhang
Corporate Culture & Public Relations Director
Shanghai MicroPort Medical (Group) Co., Ltd. (HQ)
Tel: (86)(21) 38954600-6989
Email: spokesperson@microport.com

 

[Prev]:MicroPort® Lifesciences Attends 2017 CEA Annual Meeting
[Next]:MicroPort® Orthopedics Hosts US-Chinese Surgeons Academic Exchange Program